ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 707

Subclinical Parameters of Arterial Stiffness and Arteriosclerosis Correlate with QRISK3 in Systemic Lupus Erythematosus

Monica Vazquez-Del Mercado1,2, Felipe Perez-Vazquez3, Eduardo Gomez-Bañuelos1, Efrain Chavarria-Avila3, Arcelia Llamas-Garcia4, Karla I. Arrona-Rios4, Gustavo I Diaz-Rubio3, Sergio Duran-Barragan4, Rosa E Navarro-Hernandez3, Bethel Jordan-Estrada3, Natalia Prado-Bachega5, Miguel A. A. Gonzalez-Beltran3, Carlos G Ramos-Becerra6, Fernando Grover-Paez6, David Cardona-Muller7 and Ernesto German Cardona-Muñoz7, 1Servicio de Reumatología, 004086 PNPC CONACyT, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico, 2Centro Universitario de Ciencias de la Salud, Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara Centro Universitario de Ciencias de la Salud, Guadalajara, Mexico, 3Centro Universitario de Ciencias de la Salud, Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, Universidad de Guadalajara, Guadalajara, Mexico, 4Servicio en Reumatología, 004086 PNPC CONACyT, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico, 5Anesthesiology, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico, 6Centro Universitario de Ciencias de la Salud, INTEC, Universidad de Guadalajara, Guadalajara, Mexico, 7Departamento de Fisiología, Universidad de Guadalajara, Centro Universitario de Ciencias de la Salud, Jalisco, Mexico

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Arteriosclerosis, cardiovascular disease and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, October 21, 2018

Title: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

It is well known that cardiovascular diseases (CVD) are a major contributor of death in systemic lupus erythematosus (SLE) as well in other rheumatic illness. In the last decades, there has been a growing development of different methodologies with the purpose of early detection of CVD. The aim of this study is to correlate the usefulness of subclinical parameters of vascular aging and QRISK¨ 3-2017 score for early detection of CVD in SLE.

Methods:

Clinical assessment including systemic lupus erythematosus disease activity index (SLEDAI) and systemic lupus international collaborating clinics / american college of rheumatology damage index (SLICC/ACR DI), laboratory measurements, carotid ultrasound examination, carotid intima media thickness (cIMT) measurement, carotid distention and diameter analysis, arterial stiffness measurement measured by tonometry and QRISK¨ 3-2017 were done. All results were analyzed by SPSS 24 software.

Results:

We observed correlation between QRISK3 and mean cIMT (rs = 0.651, P < 0.001), PWV (rs = 0.627, P < 0.001), cfPWV (rs = 0.651, P < 0.001) and distensibility (rs = 0.555, P = 0.001). Consistent with above, SLE patients in middle and high risk QRISK¨ 3-2017 showed increased arterial stiffness versus low risk group.

Conclusion:

We encourage to the rheumatology community to assess cardiovascular risk in SLE patients with QRISK¨ 3-2017 risk calculator as an alternative method at the outpatient clinic along a complete cardiovascular evaluation when appropriate.


Disclosure: M. Vazquez-Del Mercado, None; F. Perez-Vazquez, None; E. Gomez-Bañuelos, None; E. Chavarria-Avila, None; A. Llamas-Garcia, None; K. I. Arrona-Rios, None; G. I. Diaz-Rubio, None; S. Duran-Barragan, None; R. E. Navarro-Hernandez, None; B. Jordan-Estrada, None; N. Prado-Bachega, None; M. A. A. Gonzalez-Beltran, None; C. G. Ramos-Becerra, None; F. Grover-Paez, None; D. Cardona-Muller, None; E. G. Cardona-Muñoz, None.

To cite this abstract in AMA style:

Vazquez-Del Mercado M, Perez-Vazquez F, Gomez-Bañuelos E, Chavarria-Avila E, Llamas-Garcia A, Arrona-Rios KI, Diaz-Rubio GI, Duran-Barragan S, Navarro-Hernandez RE, Jordan-Estrada B, Prado-Bachega N, Gonzalez-Beltran MAA, Ramos-Becerra CG, Grover-Paez F, Cardona-Muller D, Cardona-Muñoz EG. Subclinical Parameters of Arterial Stiffness and Arteriosclerosis Correlate with QRISK3 in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/subclinical-parameters-of-arterial-stiffness-and-arteriosclerosis-correlate-with-qrisk3-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subclinical-parameters-of-arterial-stiffness-and-arteriosclerosis-correlate-with-qrisk3-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology